Lv3
350 积分 2022-02-18 加入
Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK
1个月前
已完结
A case of synchronous multiple primary lung cancers each harboring an EGFR mutation or an ALK fusion gene alone that responded to osimertinib with chemotherapy
1个月前
已关闭
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
3个月前
已完结
Out with the old, in with the new: what changes in the 9th edition of the TNM classification for lung cancer?
5个月前
已完结
[Advances in diagnosis and treatment and whole process management of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer]
7个月前
已关闭
Brigatinib activates inflammasomes: Implication for immune-related adverse events
8个月前
已完结
皖公网安备34019202002308
